MARKET

NAGE

NAGE

Niagen Bioscience, Inc
NASDAQ
2.440
+0.010
+0.41%
After Hours: 2.430 -0.01 -0.41% 19:30 10/26 EDT
OPEN
2.430
PREV CLOSE
2.430
HIGH
2.450
LOW
2.385
VOLUME
405.83K
TURNOVER
--
52 WEEK HIGH
7.95
52 WEEK LOW
2.385
MARKET CAP
193.07M
P/E (TTM)
12.99
1D
5D
1M
3M
1Y
5Y
1D
Niagen Bioscience launches Niagen At-Home Injection Kit
TipRanks · 4d ago
Niagen Bioscience Launches Niagen™ Plus Liquid At-Home Injections to Support Telehealth Expansion
Barchart · 4d ago
Niagen Bioscience announces debut of Tru Niagen Skincare
TipRanks · 6d ago
Niagen Bioscience Makes Skincare a Permanent Tru Niagen® Category, Launching Dermatologist-Tested Niagen NanoCloud™ as a Core Tru Niagen® Product
Barchart · 6d ago
Weekly Report: what happened at NAGE last week (1012-1016)?
Weekly Report · 10/19 09:18
Analysts Are Bullish on Top Consumer Goods Stocks: Niagen Bioscience (NAGE), Ollie’s Bargain Outlet Holding (OLLI)
TipRanks · 10/12 12:10
Weekly Report: what happened at NAGE last week (1005-1009)?
Weekly Report · 10/12 09:19
Andrew Shao, Ph.D., Senior Vice President of Global Regulatory and Scientific Affairs at Niagen Bioscience, Honored with the 2026 Annette Dickinson Trailblazer Award by Radicle Science and Council for Responsible Nutrition (CRN)
Barchart · 10/08 07:32
More
About NAGE
Niagen Bioscience, Inc. is a global bioscience company promoting healthy aging. Its segments include Consumer Products, Ingredients segment, Analytical Reference Standards and Services and Pharmaceuticals. The Consumer Products segment provides finished dietary supplement products that contain its proprietary ingredient, Niagen, directly to consumers and distributors. The ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and outsourcing facilities. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services. The Pharmaceutical segment comprises pharmaceutical development of its proprietary molecules for potential therapeutic applications in rare diseases and conducts research and development activities.

Webull offers Niagen Bioscience Inc stock information, including NASDAQ: NAGE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NAGE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NAGE stock methods without spending real money on the virtual paper trading platform.